Referenceprogram for behandling af knæartrose - Sundhedsstyrelsen
Referenceprogram for behandling af knæartrose - Sundhedsstyrelsen Referenceprogram for behandling af knæartrose - Sundhedsstyrelsen
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMe d&dopt=Citation&list_uids=17012421 8) Andereya, S., Mumme, T., Muller-Rath, R., & Schneider, U. 2004, "Welche Faktoren beeinflussen das Ergebnis der ACT bei Ueberschreiten der Indikationsgrenzen?", Z Orthop Ihre Grenzgeb, vol. 142, no. 6, pp. 651-658. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&d opt=Citation&list_uids=15614643 9) Anderson, J. G., Wixson, R. L., Tsai, D., Stulberg, S. D., & Chang, R. W. 1996, "Functional outcome and patient satisfaction in total knee patient over the age of 75", The Journal of arthroplasty, vol. 11, no. 7, pp. 831-840. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&d opt=AbstractPlus&list_uids=8934323&query_hl=8&itool=pubmed_docsum 10) Armstrong, C. P. & Blower, A. L. 1987, "Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration", Gut, vol. 28, no. 5, pp. 527-532. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&d opt=Citation&list_uids=3596334 11) Astorga, P. G., Baigun, S., Galvao de, F. J., & Gomes de, F. G. 1991, "Efficacy and tolerability comparison of etodolac and piroxicam in the treatment of patients with osteoarthritis of the knee", Curr.Med.Res.Opin., vol. 12, no. 6, pp. 401-412. 11b Avenell A., Brown T. J., McGee M. A., Campbell M. K., Grant A. M., Broom J., Jung R. T., & Smith W. C. 2004, "What are the long-term benefits of weight reducing diets in adults? A systematic review of randomized controlled trials", J Hum Nutr Diet., vol. 17, no. 4, pp. 317-335. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMe d&dopt=Citation&list_uids=15250842 12) Ayral, X., Mackillop, N., Genant, H. K., Kirkpatrick, J., Beaulieu, A., Pippingskiold, P., Will, R. K., Alava, S., & Dougados, M. 2003, "Arthroscopic evaluation of potential structure-modifying drug in osteoarthritis of the knee. A multicenter, randomized, double-blind comparison of tenidap sodium vs piroxicam", Osteoarthritis.Cartilage., vol. 11, no. 3, pp. 198-207. http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_ui ds=12623291&dopt 13) Babul, N., Noveck, R., Chipman, H., Roth, S. H., Gana, T., & Albert, K. 2004, "Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee", J Pain Symptom Manage., vol. 28, no. 1, pp. 59-71. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&d opt=Citation&list_uids=15223085 14) Bach, K. F. & Hallas, J. 2002, "Paracetamol - risiko for GI-bivirkninger?", Rationel Farmakoterapi, vol. 3, no. 1, pp. 2-3. http://www.irf.dk/dk/publikationer/rationel_farmakoterapi/maanedsblad/2002/pa racetamol_-_risiko_for_gi-bivirkninger_02.htm Referenceprogram for behandling af knæartrose – september 2007 72
15) Bagge, E., Bjelle, A., Eden, S., & Svanborg, A. 1991, "Osteoarthritis in the elderly: clinical and radiological findings in 79 and 85 year olds", Annals of the Rheumatic Diseases, vol. 50, no. 8, pp. 535-539. 16) Baker, K. R., Nelson, M. E., Felson, D. T., Layne, J. E., Sarno, R., & Roubenoff, R. 2001, "The efficacy of home based progressive strength training in older adults with knee osteoarthritis: a randomized controlled trial", J Rheumatol, vol. 28, no. 7, pp. 1655-1665. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&d opt=Citation&list_uids=11469475 17) Battisti, E., Piazza, E., Rigato, M., Nuti, R., Bianciardi, L., Scribano, A., & Giordano, N. 2004, "Efficacy and safety of a musically modulated electromagnetic field (TAMMEF) in patients affected by knee osteoarthritis", Clinical and experimental rheumatology, vol. 22, no. 5, pp. 568-572. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&d opt=Citation&list_uids=15485009 18) Battisti, W. P., Katz, N. P., Weaver, A. L., Matsumoto, A. K., Kivitz, A. J., Polis, A. B., & Geba, G. P. 2004, "Pain management in osteoarthritis: a focus on onset of efficacy--a comparison of rofecoxib, celecoxib, acetaminophen, and nabumetone across four clinical trials", J.Pain, vol. 5, no. 9, pp. 511-520. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&d opt=Citation&list_uids=15556830 19) Baumgaertner, M. R., Cannon, W. D., Jr., Vittori, J. M., Schmidt, E. S., & Maurer, R. C. 1990, "Arthroscopic debridement of the arthritic knee", Clin.Orthop Relat Res. no. 253, pp. 197-202. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&d opt=Citation&list_uids=2317974 20) Bautch, J. C., Malone, D. G., & Vailas, A. C. 1997, "Effects of exercise on knee joints with osteoarthritis: a pilot study of biologic markers", Arthritis Care Res, vol. 10, no. 1, pp. 48-55. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&d opt=Citation&list_uids=9313390 21) Beaupre, L. A., Lier, D., Davies, D. M., & Johnston, D. B. 2004, "The effect of a preoperative exercise and education program on functional recovery, health related quality of life, and health service utilization following primary total knee arthroplasty", The Journal of rheumatology, vol. 31, no. 6, pp. 1166- 1173. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&d opt=Citation&list_uids=15170931 22) Behrens, P., Bosch, U., Bruns, J., Erggelet, C., Esenwein, S. A., Gaissmaier, C., Krackhardt, T., Lohnert, J., Marlovits, S., Meenen, N. M., Mollenhauer, J., Nehrer, S., Niethard, F. U., Noth, U., Perka, C., Richter, W., Schafer, D., Schneider, U., Steinwachs, M., & Weise, K. 2004, "Indikations- und Durchfuehrungsempfehlungen der Arbeitsgemeinschaft Geweberegeneration und Gewebeersatz zur Autologen Chondrozyten-Transplantation (ACT)", Z Orthop Ihre Grenzgeb, vol. 142, no. 5, pp. 529-539. Referenceprogram for behandling af knæartrose – september 2007 73
- Page 21 and 22: 3 Behandling af knæartrose Generel
- Page 23 and 24: ter er undersøgt ved systematisk r
- Page 25 and 26: Dette må have betydning for at opr
- Page 27 and 28: overvægt er en af de vigtigste, hv
- Page 29 and 30: 3.3 Farmakologisk behandling Klinis
- Page 31 and 32: disse udelukkende inkluderer kendte
- Page 33 and 34: koen er dosisrelateret: en 2,6 gang
- Page 35 and 36: 3.3.3 Opioider Når en patient ople
- Page 37 and 38: Glukosamin mangler således klinisk
- Page 39 and 40: en vigtig plads. Imidlertid har Bha
- Page 41 and 42: til tokammerartrose korrelerer med
- Page 43 and 44: En række andre præoperative forho
- Page 45 and 46: For begge sandsynligheder vil der v
- Page 47 and 48: B Grundet reduktion af funktionsniv
- Page 49 and 50: 3.5 Anden behandling 3.5.1 Patientu
- Page 51 and 52: 3.5.2.2 Magnetisk bandage Det har v
- Page 53 and 54: (59;302). Behandlingen er således
- Page 55 and 56: B Effekten af hælkiler er for dår
- Page 57 and 58: konsekvenser for de indirekte omkos
- Page 59 and 60: ligt at motivere deltagere til rege
- Page 61 and 62: gæld er der rapporteret øget hypp
- Page 63 and 64: aggrund blev det konkluderet, at kn
- Page 65 and 66: 5 Perspektiver 5.1 Træning Konklus
- Page 67 and 68: handlerkontakt, hvorfor det næppe
- Page 69 and 70: Appendiks 1 Litteratursøgning Litt
- Page 71: Litteraturliste 1) 2000, "Recommend
- Page 75 and 76: http://www.ncbi.nlm.nih.gov/entrez/
- Page 77 and 78: 44) Brouwer, R. W., Jakma, T. S., V
- Page 79 and 80: http://www.ncbi.nlm.nih.gov/entrez/
- Page 81 and 82: http://www.ncbi.nlm.nih.gov/entrez/
- Page 83 and 84: 90) Fransen, M., Crosbie, J., & Edm
- Page 85 and 86: 104) Harrison, M. M., Morrell, J.,
- Page 87 and 88: 120) Hirano, P. C., Laurent, D. D.,
- Page 89 and 90: 137) Juni, P., Rutjes, A. W., & Die
- Page 91 and 92: 154) Langman, M. J., Weil, J., Wain
- Page 93 and 94: 168) Madsbad, S. & Richelsen, B. 20
- Page 95 and 96: 182) Mazzuca, S. A., Brandt, K. D.,
- Page 97 and 98: "A controlled trial of arthroscopic
- Page 99 and 100: among older adults with knee osteoa
- Page 101 and 102: 227) Rijk, P. C. 2004, "Meniscal al
- Page 103 and 104: 242) Schroder, H. M., Berthelsen, A
- Page 105 and 106: http://www.ncbi.nlm.nih.gov/entrez/
- Page 107 and 108: 269) Towheed, T. E. & Hochberg, M.
- Page 109 and 110: 284) Walker, J. S., Sheather-Reid,
- Page 111: 299) Wyatt, F. B., Milam, S., Mansk
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMe<br />
d&dopt=Citation&list_uids=17012421<br />
8) Andereya, S., Mumme, T., Muller-Rath, R., & Schneider, U. 2004, "Welche<br />
Faktoren beeinflussen das Ergebnis der ACT bei Ueberschreiten der Indikationsgrenzen?",<br />
Z Orthop Ihre Grenzgeb, vol. 142, no. 6, pp. 651-658.<br />
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&d<br />
opt=Citation&list_uids=15614643<br />
9) Anderson, J. G., Wixson, R. L., Tsai, D., Stulberg, S. D., & Chang, R. W.<br />
1996, "Functional outcome and patient satisfaction in total knee patient over<br />
the age of 75", The Journal of arthroplasty, vol. 11, no. 7, pp. 831-840.<br />
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&d<br />
opt=AbstractPlus&list_uids=8934323&query_hl=8&itool=pubmed_docsum<br />
10) Armstrong, C. P. & Blower, A. L. 1987, "Non-steroidal anti-inflammatory<br />
drugs and life threatening complications of peptic ulceration", Gut, vol. 28, no.<br />
5, pp. 527-532.<br />
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&d<br />
opt=Citation&list_uids=3596334<br />
11) Astorga, P. G., Baigun, S., Galvao de, F. J., & Gomes de, F. G. 1991, "Efficacy<br />
and tolerability comparison of etodolac and piroxicam in the treatment of<br />
patients with osteoarthritis of the knee", Curr.Med.Res.Opin., vol. 12, no. 6,<br />
pp. 401-412.<br />
11b Avenell A., Brown T. J., McGee M. A., Campbell M. K., Grant A. M.,<br />
Broom J., Jung R. T., & Smith W. C. 2004, "What are the long-term benefits<br />
of weight reducing diets in adults? A systematic review of randomized<br />
controlled trials", J Hum Nutr Diet., vol. 17, no. 4, pp. 317-335.<br />
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMe<br />
d&dopt=Citation&list_uids=15250842<br />
12) Ayral, X., Mackillop, N., Genant, H. K., Kirkpatrick, J., Beaulieu, A., Pippingskiold,<br />
P., Will, R. K., Alava, S., & Dougados, M. 2003, "Arthroscopic<br />
evaluation of potential structure-modifying drug in osteoarthritis of the knee. A<br />
multicenter, randomized, double-blind comparison of tenidap sodium vs piroxicam",<br />
Osteoarthritis.Cartilage., vol. 11, no. 3, pp. 198-207.<br />
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_ui<br />
ds=12623291&dopt<br />
13) Babul, N., Noveck, R., Chipman, H., Roth, S. H., Gana, T., & Albert, K.<br />
2004, "Efficacy and s<strong>af</strong>ety of extended-release, once-daily tramadol in chronic<br />
pain: a randomized 12-week clinical trial in osteoarthritis of the knee", J Pain<br />
Symptom Manage., vol. 28, no. 1, pp. 59-71.<br />
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&d<br />
opt=Citation&list_uids=15223085<br />
14) Bach, K. F. & Hallas, J. 2002, "Paracetamol - risiko <strong>for</strong> GI-bivirkninger?",<br />
Rationel Farmakoterapi, vol. 3, no. 1, pp. 2-3.<br />
http://www.irf.dk/dk/publikationer/rationel_farmakoterapi/maanedsblad/2002/pa<br />
racetamol_-_risiko_<strong>for</strong>_gi-bivirkninger_02.htm<br />
<strong>Referenceprogram</strong> <strong>for</strong> <strong>behandling</strong> <strong>af</strong> knæartrose – september 2007 72
Change language